← Leaderboards
Oh Sung Kwon
University Of Connecticut Storrs
$403,605
Attributed
$403,605
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $134.5K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$403,605 · 1
By mechanism
K01$403,605 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Storrs
Same institution · by research overlap
- Alexandros Makriyannis$48,379,340
- Matthew Kyle Hadden$3,132,064
- Kenneth G Campellone$3,714,890
- Raman Bahal$2,703,154
- Keith M Bellizzi$1,433,791
Others in their field
Other Rising Stars on “Chronic Disease”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- James Cappo · National Jewish Health$9,298,220
- Christine W Hockett · Avera Mckennan$8,908,366
- Iii, Josiah J. Sampson · Tougaloo College$8,000,000
- Rosianna R Gray · Stillman College$7,999,408
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
Research focus
Chronic DiseaseAdultCerebrumChronicAlzheimer&AposAnimal ModelAgingAntioxidantsAtherosclerosisAgreementBiologicalBiological AgingBiological AvailabilityBiological MarkersBlood Flow VelocityBlood VesselsBrainCardiovascular DiseasesCardiovascular PhysiologyCardiovascular Risk FactorCerebral HypoperfusionCerebrovascularCerebrovascular SystemClinical Trials
Grant awards (3)
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults$134,535
K01 · FY2025 · AG · contact PI
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults$134,535
K01 · FY2024 · AG · contact PI
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults$134,535
K01 · FY2023 · AG · contact PI